Is initial serum (1,3)-β-d-glucan truly associated with mortality in patients with candidaemia? Authors' response

Clin Microbiol Infect. 2016 Jun;22(6):579. doi: 10.1016/j.cmi.2016.02.012. Epub 2016 Mar 10.

Authors

D R Giacobbe¹, C Viscoli², E Furfaro², A L Colombo³, V Del Bono²

Affiliations

¹ Clinica Malattie Infettive, DIPMI, DISSAL, IRCCS San Martino-IST, Università di Genova, Genova, Italy. Electronic address: daniele.roberto.giacobbe@gmail.com.
² Clinica Malattie Infettive, DIPMI, DISSAL, IRCCS San Martino-IST, Università di Genova, Genova, Italy.
³ Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil.

PMID: 26970047
DOI: 10.1016/j.cmi.2016.02.012

No abstract available

Publication types

Letter

MeSH terms

Candidemia / diagnosis*
Candidemia / mortality*
Candidemia / pathology
Humans
Prognosis
Proteoglycans
Serum / chemistry*
Survival Analysis
beta-Glucans / blood*

Substances

Proteoglycans
beta-Glucans
polysaccharide-K